Avalo Therapeutics, Inc. · NASDAQ:AVTX

Affinity Asset Advisors, LLC reported a 5.70% stake in Avalo Therapeutics, Inc. (Schedule 13G/A)

Event Jan 22, 2026 · Filed Jan 29, 2026

Affinity Asset Advisors, LLC reported a 5.70% stake in Avalo Therapeutics, Inc., 1,051,054 shares, as a passive investor on Jan 22, 2026. Filed Jan 29, 2026 (Schedule 13G/A).

Stake
5.70%
Shares
1,051,054
Intent
Passive
What changed
Stake changed
Filed together
2 holders

The filing in full

HolderStakeShares
Affinity Asset Advisors, LLC5.70%1,051,054
Michael Cho5.70%1,051,054

Source

View original at SEC

Related